Cart
Rx 🏭 GSK ❄️ Cold Chain 🧒 Junior 720 🌍 Travel Ready 💉 2-Dose Series
HAVRIX-720 Inactivated Hepatitis A Vaccine by GSK Box Label

HAVRIX® 720 · GlaxoSmithKline · 0.5 mL Prefilled Syringe · Intramuscular Injection

HAVRIX-720 composition 720 ELISA Units inactivated Hepatitis A virus

720 ELISA Units · Formaldehyde Inactivated · Aluminium Hydroxide Adjuvant · GSK India

HAVRIX-720 – Inactivated Hepatitis A Vaccine (Junior) by GSK

Full Name: Hepatitis A Vaccine (Inactivated, Adsorbed) I.P. |  Brand: HAVRIX® 720 |  Manufacturer: GlaxoSmithKline (GSK) |  MRP: ₹2,528 |  Our Price: ₹2,401.60 (5% OFF) |  Pack: 1 × 0.5 mL Prefilled Syringe |  Route: Intramuscular Injection |  Age Group: 1–15 Years (Junior/Paediatric)

✓ GSK GlaxoSmithKline ❄️ Cold Chain 👩‍⚕️ Certified Nurse ⭐ 2-Dose Protection 💉 Inactivated Vaccine
HAVRIX-720 is an Inactivated Hepatitis A Vaccine manufactured by GlaxoSmithKline (GSK), formulated as the Junior (paediatric) presentation for children and adolescents aged 1 to 15 years. Each 0.5 mL dose contains 720 ELISA Units of formaldehyde-inactivated Hepatitis A virus adsorbed on aluminium hydroxide. Given as a 2-dose schedule, it provides long-term protection against Hepatitis A infection. Available at VacciHub at ₹2,401.60 per dose (5% OFF MRP ₹2,528) with home vaccination across Delhi NCR by certified nurses with end-to-end cold chain guarantee.
🧬 Why HAVRIX-720 Junior Protects Children Effectively
ANTIGEN
720 ELISA Units Inactivated HAV (Strain HM175)
Adsorbed on aluminium hydroxide
SCHEDULE
2 Doses: Day 0 and 6–12 Months
Provides long-term immunity
SAFETY
No Live Virus – Cannot Cause Hepatitis A
Excellent tolerability in children
PAEDIATRIC FORMULATION – AGES 1–15 YEARS

👥 Who Should Get HAVRIX-720?

Hepatitis A vaccination is recommended from 1 year of age and remains relevant through adolescence for specific risk groups. HAVRIX-720 (Junior) is especially important for:

👶

Children 1–15 Years

HAVRIX-720 Junior is specifically formulated for children and adolescents. Early vaccination protects against a common, highly contagious liver infection spread through contaminated food and water.

🏠

Household Contacts

Family members and close contacts of a person diagnosed with Hepatitis A should be vaccinated promptly to help prevent household transmission.

✈️

International & Domestic Travellers

Children travelling to areas with poor sanitation or active Hepatitis A outbreaks benefit from vaccination at least 2–4 weeks before travel.

🍽️

Food Handler Households

Families involved in food service or catering benefit from vaccination to reduce transmission risk within the household and community.

🫁

Chronic Liver Disease

Children with any underlying chronic liver condition are at higher risk of severe Hepatitis A illness and should be vaccinated as advised by their doctor.

🏫

Daycare & School Attendees

Children in daycare centres and schools are at higher risk of exposure due to close contact with other children.

🩺

High Exposure-Risk Individuals

Individuals with occupational, medical or lifestyle exposure risk factors, as identified by a physician, are recommended to receive Hepatitis A vaccination.

👨‍👩‍👧‍👦

Whole Family Vaccination

Book a VacciHub home visit to vaccinate siblings and family members together, reducing repeat visits and ensuring complete household protection.

🔬 HAVRIX-720 Composition – Per 0.5 mL Dose

Each 0.5 mL pre-filled syringe contains, as per GSK manufacturer specifications:

ACTIVE INGREDIENT
Hepatitis A virus (strain HM175)
Inactivated
720 ELISA UnitsInactivated by formaldehyde, propagated in MRC-5 human diploid cells
PRODUCTION AND INACTIVATION
Propagation mediumMRC-5 human diploid cellsHuman diploid cell line used for viral propagation
Inactivation methodFormaldehydeEnsures the vaccine contains no live virus
ADJUVANT AND EXCIPIENTS
AdjuvantAluminium hydroxide (hydrated)Enhances and prolongs the immune response
Preservative2-Phenoxyethanol (trace)Preservative used during manufacturing
Residual tracesFormaldehyde, Neomycin sulphate (trace)From manufacturing process; relevant for individuals with known allergy
Other excipientsAmino acids, Polysorbate 20, Water for injectionStandard formulation components
ℹ️ Notice for allergy history: HAVRIX-720 is produced using MRC-5 human diploid cells and may contain trace neomycin. Please inform your VacciHub nurse of any known allergies before vaccination.

📅 HAVRIX-720 Vaccination Schedule

Age / GroupDosesTimingNotes
Children 1–15 years (Primary Dose) 1 Dose Day 0 (as advised by paediatrician) First dose in the 2-dose primary series
Children 1–15 years (Booster Dose) 1 Dose 6–12 months after Dose 1 Completes the primary series; provides long-term protection
Catch-up Vaccination 2 Doses 0 and 6–12 months, from any age 1 year+ Can be started at any age from 1 year if missed earlier
ℹ️ Best practice: The 2nd (booster) dose should ideally be given between 6 to 12 months after the first dose. If delayed beyond 12 months, the booster can still be given — there is no need to restart the series.

⚙️ How Does HAVRIX-720 Work?

1
Inactivated Antigen Injected Intramuscularly 0.5 mL of HAVRIX-720 is injected IM into the deltoid (or anterolateral thigh in younger children). The dose delivers 720 ELISA Units of formaldehyde-inactivated Hepatitis A virus. No live virus is present — the vaccine cannot cause Hepatitis A infection.
2
Immune System Recognition Antigen-presenting cells at the injection site process the inactivated viral antigens and present them to T-helper cells, initiating the adaptive immune response.
3
Antibody Production (2–4 Weeks) B-cells produce protective antibodies against Hepatitis A virus, with protective levels typically achieved within 2 to 4 weeks of the first dose.
4
Long-Term Protection After Booster The second (booster) dose at 6–12 months triggers a strong immune memory response, providing long-term protection against Hepatitis A estimated to last for many years.
Cannot cause Hepatitis A: HAVRIX-720 is a completely inactivated vaccine — no live or attenuated virus whatsoever. It is physiologically impossible to contract Hepatitis A from HAVRIX-720. Mild soreness or low-grade fever after vaccination are normal immune activation responses, not infection.

⚠️ HAVRIX-720 Side Effects

HAVRIX-720 has an excellent safety record in children. Most side effects are mild and resolve within 1–2 days. Our VacciHub nurses monitor all patients post-vaccination before leaving.

🟡 Very Common and Common (Mild, 1–2 Days)
  • 💉 Injection-site pain or soreness
  • 🔴 Redness or swelling at injection site
  • 🍽️ Loss of appetite
  • 🤕 Headache (mild, in older children)
  • 😢 Irritability or fussiness (younger children)
  • 🌡️ Low-grade fever (below 38°C)
🔴 Rare — Seek Medical Attention Immediately
  • 🚨 Severe allergic reaction (anaphylaxis) — extremely rare
  • 🌡️ High fever (above 39°C)
  • 🤮 Persistent vomiting
  • 😮‍💨 Difficulty breathing or facial/throat swelling
  • 😴 Unusual drowsiness or seizure

⚖️ HAVRIX-720 vs Other Hepatitis A Vaccines at VacciHub

FeatureHAVRIX-720 (GSK)HAV Shield (Abbott)HAVISURE (IIL)
Vaccine TypeInactivated Hepatitis A VaccineInactivated Hepatitis A VaccineInactivated Hepatitis A Vaccine
FormulationJunior (Paediatric)0.5 mL PFSPaediatric
Dose Schedule2 doses (0, 6–12 months)2 doses (0, 6–12 months)2 doses (0, 6–12 months)
MRP₹2,528₹2,515₹1,980
VacciHub Price (5% OFF)₹2,401.60₹2,389.25₹1,881.00
ManufacturerGlaxoSmithKlineAbbott IndiaIndian Immunologicals Ltd (IIL)

Note: All Hepatitis A vaccines listed follow a similar 2-dose inactivated vaccine schedule. Consult your doctor or VacciHub nurse to choose the right brand for your child.

🚫 Precautions and Contraindications

Do NOT give HAVRIX-720 if:

  • Child has had a severe allergic reaction (anaphylaxis) to a previous dose of HAVRIX or any of its components
  • Known hypersensitivity to neomycin or any vaccine excipient
  • Child has a moderate to severe acute illness with fever — defer vaccination until recovery

Use with Caution — Consult Doctor First:

  • Bleeding disorders or anticoagulant therapy — inform VacciHub nurse before vaccination
  • Immunocompromised children — may have a reduced immune response; vaccination is still generally recommended
  • Pregnant or breastfeeding adolescents — consult your doctor before vaccination
⚠️ Storage requirements: HAVRIX-720 must be stored at 2°C to 8°C. Do NOT freeze. Protect from light. VacciHub nurses transport HAVRIX-720 in validated cold-chain boxes with temperature data loggers to ensure 2–8°C compliance from our storage to your home.

🏥 Why Book HAVRIX-720 with VacciHub?

👩‍⚕️

Certified Nursing Staff

Trained, certified nurses experienced in paediatric vaccination. Correct IM injection technique for children of all ages. Pre-vaccination health check included with every home visit.

❄️

End-to-End Cold Chain

HAVRIX-720 transported in validated cold-chain boxes with temperature data loggers, ensuring 2–8°C compliance from our storage to your doorstep.

Genuine GSK HAVRIX-720

Sourced through authorised distribution channels. Every vial is checked for batch number, expiry and cold-chain integrity before administration.

👨‍👩‍👧‍👦

Whole Family in One Visit

Vaccinate multiple children or family members together in a single home visit, saving time and ensuring no one misses their dose.

🧸

Child-Friendly, Gentle Technique

Our nurses use gentle, low-pain injection techniques and comforting approaches suited for infants, toddlers and adolescents.

📅

Same-Day and Weekend Slots

Flexible scheduling including evenings and weekends, so your child's vaccination doesn't disrupt school or family routines.

📍 HAVRIX-720 Home Vaccination – Cities We Serve

🏛️Delhi (All Areas)
🏙️Gurgaon
🌆Noida
🏘️Ghaziabad
🏗️Faridabad
🌇Greater Noida

Call +91 92050 04114 to confirm service availability for your specific pincode — same-day slots available in most areas.

❓ Frequently Asked Questions – HAVRIX-720

HAVRIX-720 is an Inactivated Hepatitis A Vaccine (Junior/paediatric presentation) manufactured by GlaxoSmithKline (GSK), one of the world's leading pharmaceutical companies. Each 0.5 mL dose contains 720 ELISA Units of formaldehyde-inactivated Hepatitis A virus, intended for children and adolescents aged 1 to 15 years.

Copyright © All Rights Reserved VacciHub by PSTRIDE SOLUTIONS LLP